Description
Trajenta (generic name: Linagliptin) is a prescription medication used for the management of type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). Trajenta helps to regulate blood sugar levels by increasing the levels of incretin hormones, which in turn increase insulin release and decrease glucagon levels in the blood.
Reviews
There are no reviews yet.